Bladder cancer is a global health issue with sex differences in incidence and prognosis.
Bladder cancer has distinct molecular subtypes with multiple pathogenic pathways …

Muscle-invasive bladder cancer is an aggressive disease associated with high morbidity
and mortality. Radical cystectomy is the mainstay of treatment and has evolved since the first …

Urothelial carcinoma (UC), also described as bladder cancer, is the 10th most common
cancer type worldwide, with an estimated 549 000 new cases and 200 000 deaths in 2018 …

The number of cancer survivors continues to increase in the United States because of the
growth and aging of the population as well as advances in early detection and treatment. To …

The number of cancer survivors continues to increase because of both advances in early
detection and treatment and the aging and growth of the population. For the public health …

The number of cancer survivors continues to increase in the United States due to the growth
and aging of the population as well as advances in early detection and treatment. To assist …

Purpose: This multidisciplinary, evidence-based guideline for clinically non-metastatic
muscle-invasive bladder cancer focuses on the evaluation, treatment and surveillance of …

Abstract Purpose of Review Bladder cancer (BC) is the second most common genitourinary
malignancy, with a growing population of survivors globally. Over the past two decades …

Cervix cancer in many countries is declining and screening programmes and immunisation
will reduce the incidence in the next few decades. This guideline attempts to cover …

Bladder cancer is the most common malignancy of the urinary tract and the ninth most
common malignancy in the world, with an estimated overall global 5-year prevalence of …